Artificial Lung Market

Artificial Lung Market was valued at USD 3.18 Bn in 2025 and is expected to reach USD 7.39 Bn by 2032, growing at a CAGR of 12.78% during the forecast period.

Artificial Lung Market Overview:

An Artificial Lung is a prosthetic device that provides oxygenation of blood and removal of carbon dioxide from the blood. It is intended to take over some of the functionality of biological lungs. An artificial lung must be able to sustain the gas exchange requirements of a normal functioning lung.

To Know About The Research Methodology :- Request Free Sample Report

Artificial Lung Market Dynamics:

Rising prevalence of Chronic Obstructive Pulmonary Diseases propels the global Artificial Lung market.

Chronic obstructive pulmonary diseases (COPD), represent the fourth leading cause of death worldwide. The increasing rates of tobacco smoking and exposure to air pollutants will further raise the number of COPD patients thus creating an urgent need for new therapeutic strategies. The need for a lung transplants is also rising. About 2,000 people receive a lung transplant each year in the U.S. these factors tend to drive the market for artificial lung during the forecast period. Persistent efforts from researchers and scientists for developing and improving artificial lung, which can be used at a larger scale and greater ease contribute to the market growth.

According to the news released on April 4, 2020, by ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced the recent initiation of commercial development of its next-generation artificial lung, which expands the focus on highly efficient gas exchange devices and also broadens It's an applicable market. The next generation Hemolung RAS is based upon intellectual property recently licensed to ALung from the University of Pittsburgh.
The report has profiled key players in the market from different regions. However, the report has considered all market leaders, followers, and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed.

Artificial Lung Market Segment Analysis:

In 2025, the Product segment is dominated by Membrane Artificial Lung, which represents the highest demand in the global artificial lung market. Membrane-based systems are widely preferred due to their superior gas exchange efficiency, biocompatibility, and reduced risk of blood trauma compared to bubble oxygenators. These systems are extensively used in Extracorporeal Membrane Oxygenation (ECMO) procedures and cardiothoracic surgeries.

Bubble Artificial Lung devices, while historically significant and cost-effective, are witnessing declining adoption due to safety concerns and advancements in membrane technology. Overall, membrane artificial lungs remain the standard of care and the primary revenue-generating product category in 2025.

Based on End-Users, Hospitals account for the largest share of the Artificial Lung Market in 2025. The high volume of critical care cases, availability of specialized infrastructure, and increasing number of ECMO procedures contribute to strong demand in hospital settings. Hospitals are equipped with advanced intensive care units (ICUs) and trained professionals, making them the primary centers for artificial lung deployment.

Emergency Centers are experiencing steady growth due to the rising incidence of acute respiratory failure and trauma-related complications requiring immediate respiratory support. The “Other” category, including specialty clinics and research institutes, represents a smaller but growing segment driven by innovation and clinical trials.

Artificial Lung Market Regional Insights:

Based on Region, Asia Pacific leads the global Artificial Lung Market in 2025, supported by a large patient pool, rising healthcare expenditure, and increasing adoption of advanced critical care technologies in countries such as China, Japan, and India. Expanding hospital infrastructure and growing awareness of ECMO therapy further strengthen regional dominance.

North America holds a significant share due to advanced healthcare systems, strong reimbursement frameworks, and high adoption of innovative respiratory support technologies. Europe follows with stable growth driven by well-established medical infrastructure and increasing cardiothoracic procedures.

The Middle East & Africa and South America exhibit moderate growth, primarily influenced by improving healthcare investments and gradual adoption of advanced life-support systems. The report also helps in understanding Global Artificial Lung Market dynamics, structure by analyzing the market segments and project the Global Artificial Lung Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Artificial Lung Market make the report investor’s guide.

Scope of Artificial Lung Market report: Inquire before buying

Key Players /Competitor Profiles Covered in the Artificial Lung Market Report from a Strategic Perspective.

1. ALung Technologies
2. Breethe
3. Haemair
4. Lung Biotechnology PBC
5. McGowan Institute for Regenerative Medicine
6. MedArray
7. Michigan Critical Care Consultants
8. Miromatrix Medical
9. The Charles Stark Draper Laboratory
10. Xenios
11. Medtronic
12. Getinge
13. LivaNova
14. Terumo Corporation
15. MicroPort Scientific Corporation
16. Nipro Corporation
17. Eurosets
18. Sorin Group
19. Fresenius Medical Care
20. Abiomed
21. Abbott Laboratories
22. Asahi Kasei Medical
23. Braile Biomedica
24. Oxyplus Technologies
25. Hemovent
26. Inspira Technologies